Liu, Huiling
Cui, Yongbin
Chang, Cheng
Zhou, Zichun
Zhang, Yalin
Ma, Changsheng
Yin, Yong
Wang, Ruozheng
Funding for this research was provided by:
the State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asian Fund (SKL-HIDCA-2020-GJ4)
the Key Research and Development Program of Xinjiang Uygur Autonomous Region of China (2022B03019-5)
the Special Funds Project of Central Guidance on Local Science and Technology Development (ZYYD2022B18)
Article History
Received: 24 October 2023
Accepted: 24 January 2024
First Online: 30 January 2024
Declarations
:
: This study protocol was approved by the Ethics Committee of the Affiliated Cancer Hospital of Shandong First Medical University (Approval No. SDTHEC2022009034) and the Ethics Committee of the Affiliated Cancer Hospital of Xinjiang Medical University (Approval No. k-2022006), and individual informed consent was waived for this retrospective analysis. All procedures were conducted in accordance with the ethical standards of the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.